- +91-8886781429
- +91-8019104455
- thefactdiagnostics@gmail.com
- Hyderabad, Telangana
Fact Diagnostics brings you Onco-D-clare, an advanced cancer screening test that combines molecular biology with artificial intelligence to identify cancer at its earliest stages—often before any symptoms appear.
The test works by analyzing the expression of over 90 important genes from a small blood sample. Using powerful machine learning algorithms, the test distinguishes between healthy and cancerous profiles with a high degree of accuracy (≈93%). This means individuals receive reliable insights that can guide timely medical attention, lifestyle changes, or preventive measures.
Cancer detected at an early stage is far more likely to be treated successfully. Onco-D-clare empowers individuals and healthcare providers with essential information, helping them take proactive steps toward better health and long-term well-being.
*Prices may vary depending on local taxes and distributor policies. The test does not include consultation or blood draw fees. For accurate and up-to-date details, please visit our centre.
InVyomma Plus is a specialized test by Fact Diagnostics that focuses on gut microbiome profiling and the analysis of short-chain fatty acids (SCFAs) to study their association with cancer.
Recent research has shown that the human microbiome plays a critical role in the occurrence and development of various cancers, especially in epithelial barriers and sterile tissues. The gut microbiome can influence cancer in two major ways:
By analyzing these factors, the InVyomma Plus test provides clinicians with valuable insights that can support better treatment planning, personalized care, and preventive strategies for long-term health.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
Onconomics is an advanced test offered by Fact Diagnostics that provides highly detailed and accurate information about the effectiveness of specific anticancer drugs and targeted therapies.
The test combines two powerful approaches—molecular analysis and cellular analysis—using procedures such as epigenetic profiling and viability assays. By studying how cancer cells respond at both the genetic and cellular level, Onconomics delivers a clear picture of which treatments are most likely to work for each individual patient.
A blood or tissue sample is required for the analysis, which helps identify the therapies that will be the most suitable and successful. This allows clinicians to design personalized treatment plans that improve outcomes, minimize unnecessary side effects, and avoid ineffective therapies.
Onconomics empowers both patients and doctors to make informed treatment decisions, bringing precision medicine into cancer care.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
Onconomics Plus is a highly advanced test that evaluates how specific anticancer drugs, targeted therapies, and natural treatments affect cancer cells in individual patient.
By analyzing a blood or tissue sample, the test provides clear information about the effectiveness of different treatment options. This makes it possible to identify the most suitable and successful therapies.
With these insights, clinicians can design a personalized treatment plan tailored to each patient’s unique cancer profile—helping improve outcomes, reduce side effects, and ensure more precise cancer care.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
Onconomics Extracts is a unique and highly detailed test that evaluates how effective natural substances and plant extracts are in targeting circulating tumor (cancer) cells (CTCs).
The analysis uses three scientifically proven methods to assess the response of cancer cells, offering a highly personalized evaluation for each patient.
With this information, clinicians can identify the most effective natural treatments that may be used alongside conventional therapies, supporting a more comprehensive and tailored approach to cancer care.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
Onconomics Extracts + provides highly detailed and accurate information on how effective specific natural substances and plant extracts are as anticancer agents. In addition, the test evaluates the gene expression profile of genes involved in fundamental biological processes.
These processes include angiogenesis, cell cycle regulation, DNA self-repair, metastasis, apoptosis, and proliferation—all critical pathways in cancer development and progression.
For the analysis, circulating tumor cells (CTCs) are isolated from a peripheral blood sample and subjected to multiple assays. The results help in understanding how natural treatments may complement conventional cancer therapies, offering a personalized and comprehensive analysis for each patient.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
Oncocount is a specialized test designed to detect the presence and concentration of circulating tumor cells (CTCs) in the blood. CTCs are a powerful biomarker, and their detection can serve as an early warning sign that cancer may be returning.
This test is particularly valuable as a follow-up tool for patients who have undergone cancer treatment and are concerned about recurrence. By monitoring CTC levels, Oncocount provides important insights into the effectiveness of ongoing treatment and the likelihood of cancer returning, helping clinicians adjust care plans promptly if needed.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
Oncotrace is a specialized test that helps in identifying the primary tumor (original site where cancer begins) in a patient, while also providing valuable insights into disease progression and future prognosis.
A simple blood sample is analyzed to detect the presence and concentration of circulating tumor cells (CTCs). In addition to identifying CTCs, the test also determines their specific type (immunophenotype), giving a clearer picture of the cancer’s nature.
For clinicians, Oncotrace is an important tool to help determine the origin of a tumor when it is unknown. It also offers crucial information about the development of cancer and the likely prognosis, enabling more informed and personalized treatment planning.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
Oncotrail RGCC is a specialized test designed for patients with a confirmed diagnosis of specific cancers such as breast, colon, and prostate cancer.
Using a simple blood sample, the test analyzes the presence, concentration, and immunophenotype of circulating tumor cells (CTCs). These biomarkers provide critical insights into how the cancer is behaving and how it may respond to treatment.
While not a primary diagnostic test, Oncotrail RGCC delivers valuable information about the effectiveness of current cancer therapies. It also serves as a reliable follow-up tool to help assess the risk of cancer relapse, guiding clinicians in tailoring ongoing care and monitoring disease progression.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
ArrayCGH RGCC (Array Comparative Genomic Hybridisation) is an advanced test that identifies chromosomal abnormalities in patients that may lead to the development of cancer.
Using the powerful technique of array comparative genomic hybridisation, the test can detect subtle abnormalities within the genome. These insights help in assessing an individual’s risk of developing cancer and potential location of the primary tumor.
By uncovering hidden genetic changes, ArrayCGH RGCC supports clinicians in early detection, risk evaluation, and improved treatment planning for patients at risk of cancer.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
ChemoSNiP is an advanced test that uses advanced technique called pharmacogenomics to study how a patient’s body responds to specific drugs. This cutting-edge approach helps predict both the effectiveness and potential risks of certain cancer therapies.
Blood sample is analyzed to identify single nucleotide polymorphisms (SNPs)—small variations in the DNA sequence that may influence the development of cancer or affect how the body responds to chemotherapy and other drug-based treatments.
The results provide a personalized analysis, allowing clinicians to determine the most effective combination of drugs and therapies for each patient. This ensures better treatment outcomes while minimizing unnecessary side effects.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
CAMBISeq (Cancer Analysis, Mutational Burden and Instability Sequencing) is an innovative test that uses advanced next-generation sequencing (NGS) on both DNA and RNA to predict how well a patient may respond to immunotherapy.
The test analyzes variants in 500 key genes, which are used as biomarkers to assess a patient’s sensitivity to different immunotherapy options. This information enables clinicians to determine whether immunotherapy is likely to be effective and to design a more precise treatment strategy.
CAMBISeq is especially suitable for patients with a confirmed cancer diagnosis, providing them with personalized insights that can guide treatment decisions and improve outcomes.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
Metastat is an advanced test designed to detect specific blood-borne markers that help determine the presence of secondary (metastatic) cancer and its potential location in the body.
The test works by analyzing a blood sample to identify and measure circulating tumor cells (CTCs). These markers provide important insights into whether cancer has spread beyond the primary site and where it may have progressed.
Metastat is particularly suitable for patients with a confirmed cancer diagnosis, giving clinicians vital information to guide treatment decisions and monitor disease progression.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.
Immune-Frame is a specialized test that evaluates the condition of a patient’s immune system by identifying specific cellular markers responsible for switching the immune system on and off.
By analyzing these markers, the test provides valuable insights into how well the immune system is functioning. The results offer clinicians ongoing information about a patient’s immune health status, which can be critical in guiding cancer treatment, monitoring response, and supporting overall well-being.
*Prices may vary depending on local taxes and distributor policies. For accurate details, please visit our centre.